Document Detail


A randomized, evaluator-blind, multicenter comparison of the efficacy and tolerability of Perlane versus Zyplast in the correction of nasolabial folds.
MedLine Citation:
PMID:  15622265     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Bovine collagen is widely used as a dermal filler for facial soft-tissue augmentation, but it provides only temporary cosmetic improvement. Nonanimal stabilized hyaluronic acid has reduced potential for immunogenicity and hypersensitivity and may provide a more durable aesthetic result. Sixty-eight patients with prominent nasolabial folds were randomized to intradermal treatment with nonanimal stabilized hyaluronic acid gel (Perlane) and bovine collagen (Zyplast) on contralateral sides of the face. On achievement of "optimal cosmetic result" (baseline), patients were followed up for 6 months; bilateral retreatment with Perlane was offered at 6 or 9 months after baseline. Responses were evaluated at 2, 4, 6, 9, and 12 months after baseline. Investigator-based and patient-based ratings indicated that Perlane was more effective than Zyplast in maintaining cosmetic correction. According to investigator-based Wrinkle Severity Rating Scale assessments at 6 and 9 months after baseline, Perlane was superior in 50.0 percent and 48.8 percent of patients, respectively, whereas Zyplast was superior in 10.3 percent and 14.0 percent of patients, respectively (p < 0.0004). Investigator-based Global Aesthetic Improvement Scale assessment at 9 months after baseline indicated that Perlane was superior in 48.8 percent of patients, whereas Zyplast was superior in 14.0 percent of patients (p = 0.0025). "Optimal cosmetic result" was achieved with a smaller volume of Perlane than Zyplast (mean, 1.2 ml versus 2.1 ml). Local injection-site reactions (redness, swelling, pruritus, and induration) were less frequent with Perlane than with Zyplast. Delayed-onset reactions were rare and did not reoccur after Perlane retreatment. Perlane has acceptable long-term safety and offers a longer-lasting aesthetic improvement than Zyplast.
Authors:
Christer Lindqvist; Stein Tveten; Bjørn Eriksen Bondevik; Dan Fagrell
Related Documents :
9112505 - Predictors of success and risk factors for attrition in the use of intracavernous injec...
20595255 - Survival and cessation in injecting drug users: prospective observational study of outc...
9202565 - Intracavernosal drug-induced erection therapy versus external vacuum devices in the tre...
7735515 - Specific hyposensitization in patients allergic to parietaria officinalis pollen allergen.
7349095 - Plasmapheresis as a supplementary treatment in pemphigus.
14627355 - Nutritional status and quality of life in patients with percutaneous endoscopic gastros...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Plastic and reconstructive surgery     Volume:  115     ISSN:  1529-4242     ISO Abbreviation:  Plast. Reconstr. Surg.     Publication Date:  2005 Jan 
Date Detail:
Created Date:  2004-12-28     Completed Date:  2005-08-22     Revised Date:  2011-02-16    
Medline Journal Info:
Nlm Unique ID:  1306050     Medline TA:  Plast Reconstr Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  282-9     Citation Subset:  AIM; IM    
Affiliation:
Göteborgs Plastikkirurgiska Center, KB, Göteborg, Sweden. lindqvist.c@goteborg.mail.telia.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Animals
Biocompatible Materials / administration & dosage,  adverse effects,  therapeutic use*
Cattle
Collagen / administration & dosage,  adverse effects,  therapeutic use*
Cosmetic Techniques*
Double-Blind Method
Erythema / chemically induced
Esthetics
Female
Gels
Humans
Hyaluronic Acid / administration & dosage,  adverse effects,  therapeutic use*
Injections, Intradermal
Male
Middle Aged
Pruritus / chemically induced
Recurrence
Skin Aging*
Time Factors
Chemical
Reg. No./Substance:
0/Biocompatible Materials; 0/Gels; 0/Perlane; 0/glutaraldehyde-cross-linked collagen; 9004-61-9/Hyaluronic Acid; 9007-34-5/Collagen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Use of immunohistochemical stains to assess the variations in color of fat of the upper eyelid.
Next Document:  Surgical design and algorithm for correction of earlobe ptosis and pseudoptosis deformity.